Total runs:
31.5K
Run Growth:
-8.5K
Growth Rate:
-26.87%
Sponsored by
PoYo.AI
FreedomIntelligence / Apollo-34B
Model's Last Updated: April 26 2024
text-generation
Introduction of Apollo-34B
Model Details of Apollo-34B
Multilingual Medicine: Model, Dataset, Benchmark, Code
Covering English, Chinese, French, Hindi, Spanish, Hindi, Arabic So far
👨🏻💻
Github
•📃
Paper
• 🌐
Demo
• 🤗
ApolloCorpus
• 🤗
XMedBench
中文
|
English
🌈 Update
- [2024.04.25] MedJamba released, train and evaluation code refer to repo .
- [2024.03.07] Paper released.
- [2024.02.12] ApolloCorpus and XMedBench is published！🎉
- [2024.01.23] Apollo repo is published！🎉
Results
🤗 Apollo-0.5B • 🤗 Apollo-1.8B • 🤗 Apollo-2B • 🤗 Apollo-6B • 🤗 Apollo-7B • 🤗 Apollo-34B • 🤗 Apollo-72B
🤗 MedJamba
🤗 Apollo-0.5B-GGUF • 🤗 Apollo-2B-GGUF • 🤗 Apollo-6B-GGUF • 🤗 Apollo-7B-GGUF
Usage Format
<|User|>:{query}\n<|Assistant|>:{response}<|endoftext|>
Dataset & Evaluation
-
Dataset 🤗 ApolloCorpus
Click to expand
- Zip File
-
Data category
-
Pretrain:
-
data item:
- json_name: {data_source} {language} {data_type}.json
- data_type: medicalBook, medicalGuideline, medicalPaper, medicalWeb(from online forum), medicalWiki
- language: en(English), zh(chinese), es(spanish), fr(french), hi(Hindi)
- data_type: qa(generated qa from text)
-
data_type==text: list of string
[ "string1", "string2", ... ] -
data_type==qa: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
data item:
-
SFT:
- json_name: {data_source}_{language}.json
- data_type: code, general, math, medicalExam, medicalPatient
-
data item: list of qa pairs(list of string)
[ [ "q1", "a1", "q2", "a2", ... ], ... ]
-
Pretrain:
-
Evaluation 🤗 XMedBench
Click to expand
-
EN:
- MedQA-USMLE
- MedMCQA
- PubMedQA : Because the results fluctuated too much, they were not used in the paper.
-
MMLU-Medical
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
ZH:
- MedQA-MCMLE
-
CMB-single
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions with single answer.
-
CMMLU-Medical
- Anatomy, Clinical_knowledge, College_medicine, Genetics, Nutrition, Traditional_chinese_medicine, Virology
-
CExam
: Not used in the paper
- Randomly sample 2,000 multiple-choice questions
-
ES: Head_qa
-
FR: Frenchmedmcqa
-
HI: MMLU_HI
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
AR: MMLU_Ara
- Clinical knowledge, Medical genetics, Anatomy, Professional medicine, College biology, College medicine
-
Results reproduction
Click to expand
Waiting for Update
Citation
Please use the following citation if you intend to use our dataset for training or evaluation:
@misc{wang2024apollo,
title={Apollo: Lightweight Multilingual Medical LLMs towards Democratizing Medical AI to 6B People},
author={Xidong Wang and Nuo Chen and Junyin Chen and Yan Hu and Yidong Wang and Xiangbo Wu and Anningzhe Gao and Xiang Wan and Haizhou Li and Benyou Wang},
year={2024},
eprint={2403.03640},
archivePrefix={arXiv},
primaryClass={cs.CL}
}
Runs of FreedomIntelligence Apollo-34B on huggingface.co
40
Total runs
0
24-hour runs
-1
3-day runs
-6
7-day runs
7
30-day runs
More Information About Apollo-34B huggingface.co Model
Url of Apollo-34B
Apollo-34B huggingface.co Url
Provider of Apollo-34B huggingface.co
Other API from FreedomIntelligence
Updated:January 17 2026
Total runs:
2.5K
Run Growth:
764
Growth Rate:
34.66%
Total runs:
1.4K
Run Growth:
800
Growth Rate:
56.62%
Total runs:
1.4K
Run Growth:
0
Growth Rate:
0.00%
Total runs:
1.3K
Run Growth:
-315
Growth Rate:
-24.21%
Total runs:
851
Run Growth:
82
Growth Rate:
9.77%
Total runs:
807
Run Growth:
80
Growth Rate:
9.31%
Total runs:
667
Run Growth:
461
Growth Rate:
69.74%
Total runs:
643
Run Growth:
410
Growth Rate:
63.76%
Total runs:
601
Run Growth:
0
Growth Rate:
0.00%
Total runs:
560
Run Growth:
-365
Growth Rate:
-65.53%
Total runs:
515
Run Growth:
-180
Growth Rate:
-36.00%
Total runs:
458
Run Growth:
148
Growth Rate:
30.33%
Total runs:
375
Run Growth:
4
Growth Rate:
1.07%
Total runs:
318
Run Growth:
291
Growth Rate:
93.87%
Total runs:
309
Run Growth:
202
Growth Rate:
64.33%
Total runs:
294
Run Growth:
-161
Growth Rate:
-54.03%
Total runs:
283
Run Growth:
28
Growth Rate:
9.76%
Total runs:
275
Run Growth:
-23
Growth Rate:
-7.47%
Total runs:
274
Run Growth:
126
Growth Rate:
45.99%
Total runs:
249
Run Growth:
-62
Growth Rate:
-25.41%
Total runs:
225
Run Growth:
-119
Growth Rate:
-53.36%
Total runs:
216
Run Growth:
-105
Growth Rate:
-45.26%
Total runs:
206
Run Growth:
177
Growth Rate:
85.10%
Total runs:
202
Run Growth:
161
Growth Rate:
79.70%
Total runs:
173
Run Growth:
86
Growth Rate:
51.50%
Total runs:
168
Run Growth:
43
Growth Rate:
26.22%
Total runs:
161
Run Growth:
114
Growth Rate:
70.81%
Total runs:
159
Run Growth:
101
Growth Rate:
64.74%
Total runs:
158
Run Growth:
16
Growth Rate:
10.19%
Total runs:
151
Run Growth:
110
Growth Rate:
91.67%
Total runs:
143
Run Growth:
108
Growth Rate:
77.14%
Total runs:
139
Run Growth:
-2
Growth Rate:
-1.39%
Total runs:
132
Run Growth:
45
Growth Rate:
33.58%
Total runs:
130
Run Growth:
114
Growth Rate:
95.00%
Total runs:
129
Run Growth:
4
Growth Rate:
3.10%
Total runs:
120
Run Growth:
-74
Growth Rate:
-60.66%
Total runs:
117
Run Growth:
-7
Growth Rate:
-6.03%
Total runs:
115
Run Growth:
0
Growth Rate:
0.00%
Total runs:
111
Run Growth:
0
Growth Rate:
0.00%
Total runs:
103
Run Growth:
1
Growth Rate:
0.97%
Total runs:
100
Run Growth:
-63
Growth Rate:
-61.76%
Total runs:
98
Run Growth:
-126
Growth Rate:
-123.53%
Total runs:
98
Run Growth:
-220
Growth Rate:
-222.22%
Total runs:
98
Run Growth:
-137
Growth Rate:
-130.48%
Total runs:
90
Run Growth:
54
Growth Rate:
54.55%
Total runs:
89
Run Growth:
73
Growth Rate:
82.02%
Total runs:
85
Run Growth:
32
Growth Rate:
35.16%
Total runs:
78
Run Growth:
68
Growth Rate:
88.31%
Total runs:
74
Run Growth:
0
Growth Rate:
0.00%
Total runs:
72
Run Growth:
-11
Growth Rate:
-15.49%
Total runs:
72
Run Growth:
-23
Growth Rate:
-30.67%
Total runs:
71
Run Growth:
52
Growth Rate:
75.36%
Total runs:
66
Run Growth:
0
Growth Rate:
0.00%
Total runs:
66
Run Growth:
-105
Growth Rate:
-156.72%
Total runs:
66
Run Growth:
6
Growth Rate:
8.70%
Total runs:
64
Run Growth:
24
Growth Rate:
36.92%
Total runs:
64
Run Growth:
7
Growth Rate:
10.94%
Total runs:
59
Run Growth:
26
Growth Rate:
44.83%
Total runs:
57
Run Growth:
13
Growth Rate:
22.03%
Total runs:
56
Run Growth:
-67
Growth Rate:
-109.84%
Total runs:
56
Run Growth:
43
Growth Rate:
76.79%
Total runs:
53
Run Growth:
0
Growth Rate:
0.00%
Total runs:
50
Run Growth:
-858
Growth Rate:
-1716.00%
Total runs:
50
Run Growth:
2
Growth Rate:
4.00%
Total runs:
45
Run Growth:
-85
Growth Rate:
-180.85%
Total runs:
45
Run Growth:
17
Growth Rate:
38.64%
Total runs:
44
Run Growth:
44
Growth Rate:
100.00%
Total runs:
43
Run Growth:
17
Growth Rate:
37.78%
Total runs:
41
Run Growth:
-38
Growth Rate:
-97.44%
Total runs:
40
Run Growth:
21
Growth Rate:
51.22%
Total runs:
40
Run Growth:
-2
Growth Rate:
-4.88%
Total runs:
37
Run Growth:
16
Growth Rate:
44.44%
Total runs:
37
Run Growth:
-3
Growth Rate:
-8.11%
Total runs:
36
Run Growth:
21
Growth Rate:
63.64%
Total runs:
35
Run Growth:
5
Growth Rate:
14.29%
Total runs:
35
Run Growth:
0
Growth Rate:
0.00%
Total runs:
35
Run Growth:
19
Growth Rate:
54.29%
Total runs:
35
Run Growth:
10
Growth Rate:
27.78%
Total runs:
32
Run Growth:
-16
Growth Rate:
-51.61%
Total runs:
31
Run Growth:
5
Growth Rate:
16.13%
Total runs:
30
Run Growth:
25
Growth Rate:
83.33%
Total runs:
26
Run Growth:
0
Growth Rate:
0.00%
Total runs:
25
Run Growth:
12
Growth Rate:
52.17%
Total runs:
24
Run Growth:
14
Growth Rate:
60.87%
Total runs:
24
Run Growth:
5
Growth Rate:
21.74%
Total runs:
24
Run Growth:
9
Growth Rate:
32.14%
Total runs:
24
Run Growth:
16
Growth Rate:
66.67%
Total runs:
23
Run Growth:
9
Growth Rate:
47.37%
Total runs:
23
Run Growth:
12
Growth Rate:
54.55%
Total runs:
22
Run Growth:
12
Growth Rate:
54.55%
Total runs:
22
Run Growth:
10
Growth Rate:
45.45%
Total runs:
22
Run Growth:
10
Growth Rate:
45.45%
Total runs:
21
Run Growth:
0
Growth Rate:
0.00%
Total runs:
21
Run Growth:
4
Growth Rate:
20.00%
Total runs:
20
Run Growth:
3
Growth Rate:
18.75%
Total runs:
18
Run Growth:
4
Growth Rate:
22.22%
Total runs:
16
Run Growth:
-2
Growth Rate:
-13.33%
Total runs:
15
Run Growth:
4
Growth Rate:
26.67%
Total runs:
15
Run Growth:
9
Growth Rate:
60.00%